US equities
|
MU
$904.90
▲+2.97%
NVDA
$217.09
▲+1.38%
AMZN
$262.45
▲+4.98%
TSLA
$368.06
▲+3.76%
AAPL
$342.94
▼-0.15%
SNDK
$1,371.12
▲+5.53%
META
$705.44
▼-0.55%
SPCX
$147.96
▲+1.32%
MU
$904.90
▲+2.97%
NVDA
$217.09
▲+1.38%
AMZN
$262.45
▲+4.98%
TSLA
$368.06
▲+3.76%
AAPL
$342.94
▼-0.15%
SNDK
$1,371.12
▲+5.53%
META
$705.44
▼-0.55%
SPCX
$147.96
▲+1.32%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about David Amsellem
Recent news which mentions David Amsellem
Why This Teva Pharmaceutical Analyst Is Turning Bullish On The Austedo Franchise
February 12, 2024
Tickers
NBIX
NEWS
TEVA
Tags
Analyst Color
Top Stories
Stories That Matter
From
Benzinga